Biotech: Page 52

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Rules Change Again

    August 2008 VIEW on Medical Education THE FORUM News of Pfizer’s decision to eliminate all direct funding for physician CME programs provided by medical education and communication companies (MECCs) — the first such move by a major pharmaceutical company — has rattled even this most dynamic of se...

    By PharmaVoice Team • Aug. 20, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Cover

    PharmaVOICE PharmaVOICE 100 THE FORUM FOR THE INDUSTRY EXECUTIVE July/August 2008 SPECIAL ISSUE 100 of the Most Inspiring People www.pharmavoice.com Download PDF

    By PharmaVoice Team • July 28, 2008
  • digital pill Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Artificial intelligence & machine learning

    After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    PharmaVOICE is delighted to publish the fourth annual special issue featuring 100 of the most inspiring individuals in the life-sciences industry. This issue has become one of my favorites and, from all accounts, one of yours as well. What’s not to love? This issue celebrates the men and women of...

    By Taren Grom • July 27, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Mentors

    Brian Corvino Mary Lacquaniti Lelia O’Connor Danita Sutton, Ph.D. MENTORING AND SHAPING THE CAREERS OF OTHERS ARE VENERABLE AND ADMIRABLE TALENTS. MENTORING TAKES PATIENCE, FORESIGHT, AND UNSELFISH DEVOTIONTO OTHERS’ SUCCESS and is a skill that is often unheralded — until now. We salute those who...

    By PharmaVoice Team • July 24, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Technologists

    Valdo Arnera, M.D. Bill Byrom, Ph.D. Philip A. Garland Keith Howells Don Schenker Rodney Spady A creative and passionate approach to pioneering new areas of technology applications and new products has enabled Dr. Bill Byrom to engender real improvements in the drug development process. For the p...

    By PharmaVoice Team • July 24, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Researchers

    Julian Adams, Ph.D. Alain D. Baron, M.D. Martine Clozel, M.D. Jean-Jacques Garaud, M.D. Amir H. Kalali, M.D. Dennis Keith, Ph.D. Nick Kenny, Ph.D. Geert J.C.M. Kolvenbag M.D., Ph.D., F.F.P.M Evan Loh, M.D. Karen Seibert, Ph.D. The Researchers PRODUCTS BECOME BRANDS BECAUSE OF THE DEDICATION AND P...

    By PharmaVoice Team • July 24, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Clinical Operations: Bringing All of the Pieces Together

    6 June 20 08 VIEW on Clinical Operations THE FORUM A recentTufts CSDD study cites research showing that the cost to develop a new biopharmaceutical is now more than $1 billion. Accordingly, clinical organizations are under growing pressure to reduce research and development costs while accelerati...

    By PharmaVoice Team • June 9, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    DIA Preview Showcase

    SPECIAL FEATURE DIA 44TH ANNUAL MEETING Representing more than 20,000 members worldwide involved in discovery, development, regulation, and marketing of bio/phar maceutical and related products, the Drug Information Association (DIA) each year has the significant task of designing an annual meeti...

    By PharmaVoice Team • May 28, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    THE OTC MARKET Plop,Plop, Fizz, Fizz Consumers are taking an increasingly active role in self medication because of rising healthcare costs, a large uninsured population, and ever more choices in OTC products. Purchasing OTC drugs also is more convenient and money is saved avoiding doctor’s visit...

    By PharmaVoice Team • May 27, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Raise your voice: Letters

    Digital Training With the emergence of digital technology as the fastest growing means of delivering brand marketing and messaging, digital training is one of the best investments agencies can make to address the increasing pressures and speed of change cited by so many of your experts in the Apr...

    By PharmaVoice Team • May 27, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Special Feature: HBA's 2008 Rising Stars

    BY TAREN GROM Nelson. CommonHealth. There is no magic formula, no set of qualities or attributes which when combined in exact pro portions spontaneously produces a leader. Cer tainly many leaders possess similar characteris tics — innovation, persuasion, charisma, etc. — but what sets a leader ap...

    By Taren Grom • April 30, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Seeding Early-Stage Research

    Future success in the pharmaceutical industry will hinge on the ability of companies to deliver novel products that meet patient needs. To do that, pharma companies are teaming up with biotech companies, launching their own biotech divisions, investing in genetics, and acquiring other companies, ...

    By Denise Myshko • April 30, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Michael V. Novinski became President and CEO of Emisphere Technologies in May 2007. Previously, he served as President of Organon USA with additional responsibility for worldwide business development and lifecycle management.While serving as Organon’s Director of Marketing and later as VP of Mark...

    By PharmaVoice Team • April 29, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    ONTHE CALENDAR May 1516 13th Annual Pharmaceutical &Biotech Licensing &Deal Making Summit Hyatt Regency NewBrunswick,New Brunswick,N.J. For more information, contact Cheryl KahanRadhuber,Strategic Research Institute, at 2129670095, email [email protected], or visit srinstitut...

    By PharmaVoice Team • April 29, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Immune Tolerance Institute (ITI), a new nonprofit company, is bringing economies of scale to translational and critical path science to build partnerships with the pharmaceutical and biotech industries, and accelerate the development of new ...

    By PharmaVoice Team • April 29, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    EXECUTIVE APPOINTMENTS AND PROMOTIONS IN THE HEALTHCARE INDUSTRY Pharma POOL John I. COOPER Former GlaxoSmithKline VP Brings Global Manufacturing and Operational Management Expertise to ICN ICN Pharmaceuticals Inc. has appointed John I. Cooper as executive VP of global manufacturing and supply. I...

    By PharmaVoice Team • April 22, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Regulatory Submissions: Improving the Process

    BY TAREN GROM IMPROVING E-STRATEGIES The inability to effectively manage complex submission documentation for new drug applications (NDAs) and other regulated dossiers is a major factor in slowing the time it takes to bring a product to market. These delays cost the lifescience industry millions ...

    By PharmaVoice Team • April 21, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Alan Holmer — The Industry's Champion

    THE INDUSTRY’S CHAMPION BY KIM RIBBINK After a weighty career in politics and the law, and now seven years into his leadership position at the Pharmaceutical Research and Manufacturers of America, Alan F. Holmer is positioning the organization to address criticisms of the industry and convey to t...

    By PharmaVoice Team • April 21, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    E-MEDIA NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES SoftWatch and InfoMedics DELIVER INTEGRATED MARKETING SOLUTION  SoftWatch Inc.and InfoMedics Inc.have launched a joint solution for optimizing patient-fulfillment programs executed simultaneously across multiple communica...

    By PharmaVoice Team • April 21, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Learning to Work With E-Learning

    Learning to work with BY ELISABETH PENA As technology continues to make highspeed communication a reality, the industry is beginning to take advantage of these tools to teach and train. Using the Internet in combination with traditional teaching principles, companies can span great distances and ...

    By PharmaVoice Team • April 17, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Spiros Jamas — A Chemical Reaction

    DR.SPIROS JAMAS is leading Enanta Pharmaceuticals by tapping the company’s primary strength in its integration of chemistry and biology to tackle new targets and specific drugdevelopment challenges from all possible angles right from the start. He is relying on the hardwon lessons learned from hi...

    By Kim Ribbink • April 17, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharma POOL Anne NOBLES Dr.Thomas VERHOEVEN Lilly Announces Personnel Changes Eli Lilly, Indianapolis, has promoted Anne Nobles to VP of corporate affairs from Strattera product team leader. Ms. Nobles has replaced Deborah Steelman, who resigned for personal reasons. In her new role, she leads go...

    By PharmaVoice Team • April 17, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    58 A ug u s t 20 03 PharmaVOICE EMEDIA NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES EDocCompliance for the Oracle platform, recently launched by Qumas, is a readytovalidate, Web based application that manages the full life cycle of regulatorycontrolled documentation without t...

    By PharmaVoice Team • April 17, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Biotech Life-Cycle Management

    10 J u n e 20 03 PharmaVOICE THE MANAGEMENTTEAM … CAROLCHERKIS,PH.D. Life sciences consultant,NewCap Partners Inc., Los Angeles; NewCap Partners is a private investment banking firm that focuses on the finance needs of middlemarket companies.For more information, visit newcap.com. TILLMAN U.GERNG...

    By PharmaVoice Team • April 17, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Emergence of the Bioscience Cluster

    36 J un e 2 003 PharmaVOICE ll drug development is local, to borrow from a popular phrase. Although pharma and biotech companies have to be focused on global issues, they still are firmly rooted in the commu nities in which they reside. State and local governments recognize the benefits to the lo...

    By PharmaVoice Team • April 16, 2008